Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Astrazeneca, Keymed Biosciences.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Argenx, Beigene, Takeda.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Inogen.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Astrazeneca, Daiichi Sankyo, Hikma, Sumitomo.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Applied, Astrazeneca, Bristol Myers, Eli Lilly, Glaukos, Keymed, Novo Nordisk, Nuvation, Pfizer, Rhythm, Tonix, Vertex.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Avita.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Accord, Celltrion, CSL Berhing, Everest, Eli Lilly, Innovent, Mesoblast, Merck.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Fennec, Humacyte, Innovent, Ionis, Santhera, Zealand Pharma.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Cardia Medical, Sequana Medical.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Aquestive, Betta, Biogencell, Limmatech, Mesoblast, Nurix, Ocuphire, PTC, Sapience , Savara, Ultragenyx, Xcovery.